PharmaBoardroom

Interview: Craig Wallace – General Manager UK and Ireland,…

Craig Wallace established the UK affiliate of Santen, the Japanese ophthalmology company, in 2014. Wallace describes the journey Santen has been on so…

Joaquin Rodrigo – General Director Iberia, Sandoz, Spain

Joaquin Rodrigo, general director of Sandoz Spain and Portugal, introduces the company’s highly diversified generics and biosimilars portfolio in…

Interview: Alicia Folgueira López – General Manager Spain…

Alnylam, pioneers in the RNA interference field, seek to bring their revolutionary medicine across Europe, and in particular Portugal before 2020. In…

The Trump Bounce for Pharma M&A

Blue-chip drug makers holding USD 200 billion in cash, mostly overseas, will start investing more of it in mergers and acquisitions (M&A) after…

Digital Assets: The Next “Must-Have” Acquisition for Big…

Digital health startups raised over USD six billion in equity financing in 2016, representing a five-year compound annual growth rate of 32 percent…

A Critical Juncture for the UK’s Vaccines Industry

Britain, home of the discovery of the world’s first ever vaccine, has long been championing a pharma sub-segment forecast to reach a global market…

Interview: Dami Qiu – Founder and CEO, EMP, China

Dami Qiu, founder and CEO of EMP, shares her personal story of how she decided to establish EMP two decades ago, the market opportunities in…

Interview: Thomas Bo Bjorn Klee – Managing Director,…

Thomas Bo Bjorn Klee, managing director of Lundbeck UK and Ireland, describes the global restructuring program Lundbeck initiated two years ago to…

Interview: Henrique Manuel Gil Martins – Chairman, SPMS,…

Henrique Manuel Gil Martins, chairman of SPMS (Shared services of the Ministry of Health) provides an insight into the uptake of technology in…

Insect Inspiration: New Frontiers in Vaccine Production

Spanish biotech ALGENEX is using insect pupae to develop high-purity vaccines more quickly and at a lower cost than conventional production methods.…

How 3D Bioprinting is Revolutionizing Personalized Medicine

With the US FDA approval of a 3D bioprinted drug in 2016, the floodgates have been opened for a new wave of innovative, personalized and customizable…

Erik Nordkamp – Managing Director, Pfizer UK

Erik Nordkamp, managing director of Pfizer UK shares his thoughts on the future of healthcare and the role that Pfizer and the UK can play in shaping…

Tagged with P